Clinical Trial Update: High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib [NA]

View source ↗

Summary

A clinical trial update indicates a study on high oxygen delivery to preserve exercise capacity in idiopathic pulmonary fibrosis patients treated with nintedani…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: University of British Columbia | Conditions: Idiopathic Pulmonary Fibrosis | NA | Status: RECRUITING